Abacavir vs Atezolizumab

Abacavir vs Atezolizumab: Overview

This comparison examines the pharmacological differences between Abacavir and Atezolizumab.

Mechanism of Action

Atezolizumab: Fully human anti-PD-L1 IgG1 monoclonal antibody blocking PD-L1 interaction with PD-1 and B7.1.

Pharmacokinetics

Half-life: Atezolizumab — 27 days.

Chemical Properties

Type: Abacavir — Small molecule; Atezolizumab — Antibody.